Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, in man
Authors:
- 1 January 1980
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 17 (2) , 81-86
Abstract
The metabolic and haemodynamic effects of three intravenous doses (0.5, 1.0 and 4.0 mg) of prenalterol, a selective β1-adrenoceptor agonist, were studied in 10 healthy male subjects. Plasma levels of prenalterol during the experiments were related to the haemodynamic effects. Prenalterol induced a dose-dependent increase in systolic blood pressure and heart rate. The maximal effects amounted to about 30 mm Hg and 15 beats/min, respectively, after the highest dose (4.0 mg). The diastolic blood pressure fell by a maximum of about 15 mm Hg. The effect of prenalterol on systolic blood pressure and heart rate persisted for about 3 h after the end of the last infusion, whereas that on diastolic blood pressure only lasted for 60 min. Compared with placebo, there was a moderate increase in plasma FFA and glycerol. A small rise in insulin level was also recorded, but no significant change was seen in other metabolic variables — triglycerides, glucose, lactate, pyruvate. Serum potassium tended to decrease and serum sodium was unchanged. The initial distribution of prenalterol was rapid (half-life 7 min) and the overall elimination rate corresponded to a plasma half-life of 2 h. A linear relationship was found between the plasma level of prenalterol and its effects on systolic blood pressure and heart rate.Keywords
This publication has 21 references indexed in Scilit:
- Cardiovascular effects of prenalterol (H133/22) in normal man.1979
- Differences in Metabolic Responses to β‐Adrenergic Stimulation after Propranolol or Metoprolol AdministrationActa Medica Scandinavica, 1979
- Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptorsAmerican Heart Journal, 1978
- CSTRIP, a Fortran IV Computer Program for Obtaining Initial Polyexponential Parameter EstimatesJournal of Pharmaceutical Sciences, 1976
- Antihypertensive Effect and Side‐effects of Bendroflumethiazide and PropranololActa Medica Scandinavica, 1976
- TREATMENT OF ATTACKS IN HYPERKALÆMIC FAMILIAL PERIODIC PARALYSIS BY INHALATION OF SALBUTAMOLThe Lancet, 1976
- Effects of metoprolol and propranolol on some metabolic responses to catecholamines in the anaesthetized dogActa Pharmacologica et Toxicologica, 1975
- Triglycerides Determination after Enzymatic Hydrolysis1974
- Automated fluorometric analysis of micromolar quantities of ATP, glucose, and lactic acidAnalytical Biochemistry, 1972
- The colorimetric micro-determination of non-esterified fatty acids in plasmaClinica Chimica Acta, 1964